"The source for European pharmaceutical biotechnology news..."
New Account

The Magazine

Issue 3

Issue 3 E-magazine
  • Previous Issues

Sponsors

Platinum Sponsors
Platinum Sponsors

Blog

Where our team of editors discuss what they think about the current NGP US Issues.

Marie Shields
Editor NGP Europe

Tough competition

The battle between generics and branded products has been going on for a long time: the claims and counter claims over Aspirin, for example, have been in process since the early 20th century.
06 Aug 2009
Drug Discovery
1 of 2 Previous | Next
Drug Discovery

The L-Factor: "We’ve got the critical mass”


Franz Humer, a lawyer by training, is CEO of F. Hoffmann-La Roche Ltd – a company whose strategy is to use innovative scientific breakthroughs to shape the future of medicine.

No Comments

Miniaturised and automated protein quantification for more efficient development of biotherapeutics


Gyros leads the world in compact disk (CD) microfluidic solutions for the life science industry, focusing on protein quantification within biotherapeutic discovery and development.

No Comments

Executive Insight: LIMS


Talking with Dave Champagne, Vice President and General Manager, and Kim Shah, Director of Marketing and Business Development, for Informatics at Thermo Fisher Scientific.

No Comments

Achieving GLP Compliance Through Deployment of LIMS


By Brigitte Staecker, Thermo Fisher Scientific

No Comments

Combined competences and a common goal


Why research collaborations are increasingly important for the pharmaceutical and biopharma industry

No Comments
1 of 2 Previous | Next